Cargando…
Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes
Despite the continued development of specialized immunosuppressive therapies in the form of monoclonal antibodies, glucocorticoids remain a mainstay in the treatment of rheumatological and auto-inflammatory disorders. Therapeutic glucocorticoids are unmatched in the breadth of their immunosuppressiv...
Autores principales: | Gado, Manuel, Baschant, Ulrike, Hofbauer, Lorenz C., Henneicke, Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008133/ https://www.ncbi.nlm.nih.gov/pubmed/35432217 http://dx.doi.org/10.3389/fendo.2022.835720 |
Ejemplares similares
-
Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo
por: Hildebrandt, Susanne, et al.
Publicado: (2018) -
Editorial: Glucocorticoid and bone: Friend or foe
por: Baschant, Ulrike, et al.
Publicado: (2022) -
Author Correction: Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo
por: Hildebrandt, Susanne, et al.
Publicado: (2020) -
SAT-586 Cold-Acclimation Prevents the Onset of Glucocorticoid-Induced Adipose Dysfunction in Male Mice
por: Gado, Manuel M, et al.
Publicado: (2020) -
RF21 | PSAT78 The beta3-Adrenergic Receptor as a Target for the Prevention of Glucocorticoid-induced Adipose Tissue Dysfunction in Rodents
por: Gado, Manuel, et al.
Publicado: (2022)